A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Nature

• Publication date

  1983-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/302714A0PMID 6835406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells

  1981cited by this paper
• A survey of transformation markers in differentiating epidermal cell lines in culture.

  1980cited by this paper
• Cell biology of breast cancer.

  1980cited by this paper
• Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine

  1980cited by this paper
• Transformation-specific secreted phosphoproteins

  1980cited by this paper
• Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

  1980cited by this paper
• Transformation-specific secreted proteins.

  1980cited by this paper
• Characterization of protein kinase activity associated with the transforming gene product of Fujinami sarcoma virus.

  1980cited by this paper
• Comparative responses of normal and malignant mouse mammary cells to modulation of surface properties.

  1980cited by this paper
• Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

  1979cited by this paper
• A survey of growth in soft agar and cell surface properties as markers for transformation in adult rat liver epithelial-like cell cultures.

  1979cited by this paper
• Microtubules and actin-containing filaments of normal, preneoplastic, and neoplastic mouse mammary epithelial cells.

  1979cited by this paper
• Transformed mammalian cells secrete specific proteins and phosphoproteins.

  1979cited by this paper
• Concanavalin A-induced agglutinability of normal, preneoplastic, and neoplastic mouse mammary cells.

  1978cited by this paper
• Virus-specific markers and virus-like particles in cell lines of tumors produced by CELO virus in Syrian golden hamsters.

  1978cited by this paper
• Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas.

  1977cited by this paper
• Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

  1975cited by this paper
• Occluding junctions and cell behavior in primary cultures of normal and neoplastic mammary gland cells

  1975cited by this paper
• Growth and structural properties of epithelial cell cultures established from normal rat liver and chemically induced hepatomas.

  1975cited by this paper
• Temperature-sensitive mutants of chemically transformed epithelial cells.

  1975cited by this paper
• Influence of seeding density on multicellular organization and nuclear events in cultures of normal and neoplastic mouse mammary epithelium.

  1974cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

  1970cited by this paper
• Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.

  1970cited by this paper
• Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes.

  1969cited by this paper

• Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model.

  2020cites this paper
• 1,2,3-Triazole tethered 1,2,4-trioxanes: Studies on their synthesis and effect on osteopontin expression in MDA-MB-435 breast cancer cells.

  2019cites this paper
• Oral Cancer

  2019cites this paper
• Exploring the separation power of mixed‐modal resins for purification of recombinant osteopontin from clarified Escherichia coli lysates

  2018cites this paper
• Osteopontin-myeloid zinc finger 1 signaling regulates transforming growth factor-ß expression in cancer

  2018cites this paper
• Small Integrin-Binding Ligand N-Linked Glycoproteins (Siblings): A Study On Human Salivary Gland Cancer

  2017influential citation
• A Study of Genetic Alterations in Cancer Progression

  2015cites this paper
• In Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue

  2015cites this paper
• Gene Expression of Osteopontin in Alopecia Areata? A Case-Controlled Study

  2014cites this paper
• Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels

  2014cites this paper
• Opposite Effects of Interferon Regulatory Factor 1 and Osteopontin on the Apoptosis of Epithelial Cells Induced by TNF-&agr; in Inflammatory Bowel Disease

  2014cites this paper
• An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer.

  2013cites this paper
• Adhesive and Cytokine-Like Properties In Sarcoid Granulomas and Has T Cell Osteopontin Is Associated with T Cells in

  2013cites this paper
• The epigenetic landscape of oral squamous cell carcinoma

  2013influential citation
• Osteopontin: Participation in Inflammation or Mucosal Protection in Inflammatory Bowel Diseases?

  2013cites this paper
• Getting from the bench to the patient: biotechnology strategies.

  2013cites this paper
• Biomarkers of prognosis and response to vitamin D in cutaneous melanoma

  2013cites this paper
• Osteopontin upregulation in atherogenesis is associated with cellular oxidative stress triggered by the activation of scavenger receptors.

  2012cites this paper
• Reduced Expression of Syndecan-1 in Oral Cancer

  2012cites this paper
• Vascular endothelial growth factor-induced permeability in the pathogenesis of cardiac allograft vasculopathy

  2011cites this paper
• Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in vitro.

  2011cites this paper
• Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria.

  2011cites this paper
• Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy

  2011cites this paper
• Intracellular pathways underlying the effects of lithium

  2010cites this paper
• Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells

  2010cites this paper
• Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.

  2010cites this paper
• Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology

  2009cites this paper
• Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer

  2009cites this paper
• The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species*

  2009cites this paper
• Uterine and ovarian vascular and architectural changes in equids and bovids; with emphasis on effect of the conceptus

  2009cites this paper
• Osteopontin: regulation in tumor metastasis

  2008cites this paper
• Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

  2008cites this paper
• Inhibition of syndecan-1 expression and function in oral cancer cells.

  2008cites this paper
• Positive Correlation of Osteopontin, Cyclooxygenase-2 and Vascular Endothelial Growth Factor in Gastric Cancer

  2008cites this paper
• Osteopontin as a molecular prognostic marker for melanoma

  2008cites this paper
• Fibroblast growth factor‐2 regulates expression of osteopontin in periodontal ligament cells

  2008cites this paper
• MacrophagesDegradation of STAT1 in RAW264.7 Murine Osteopontin Induces Ubiquitin-Dependent

  2007cites this paper
• Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.

  2007cites this paper
• Macrophages Degradation of STAT 1 in RAW 264 . 7 Murine Osteopontin Induces Ubiquitin-Dependent Grusby

  2007cites this paper
• Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.

  2007cites this paper
• Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.

  2007cites this paper
• Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy

  2007cites this paper
• Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

  2007cites this paper
• Osteopontin Induces Ubiquitin-Dependent Degradation of STAT1 in RAW264.7 Murine Macrophages1

  2007cites this paper
• Osteopontin , Fibronectin , and Laminin-transformed NIH 3 T 3 Cells to ras Adhesion of Metastatic , Updated Version

  2006cites this paper
• Lymphangiogenesis in the developing lung promoted by VEGF-A.

  2006cites this paper
• Identification of apolipoprotein D as a novel inhibitor of osteopontin-induced neoplastic transformation.

  2006cites this paper
• Expression Pattern of Osteopontin in Endometrial Carcinoma: Correlation With Expression of the Adhesion Molecule CEACAM1

  2006cites this paper
• The effects of growth factors on the production of osteopontin and osteocalcin.

  2006cites this paper
• Plasma osteopontin is an independent prognostic marker for head and neck cancers.

  2006cites this paper
• Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.

  2006cites this paper
• JNK1 Differentially Regulates Osteopontin-induced Nuclear Factorinducing Kinase/MEKK1-dependent Activating Protein-1-mediated Promatrix Metalloproteinase-9 Activation*

  2005cites this paper
• Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective.

  2005cites this paper
• The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

  2005cites this paper
• Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor.

  2005cites this paper
• Expression and function of laminins in the embryonic and mature vasculature.

  2005influential citation
• Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides.

  2005cites this paper
• Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells*

  2004cites this paper
• Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies

  2004cites this paper
• The role of Osteopontin in tumor metastasis.

  2004cites this paper
• The Role of Osteopontin in Vascular Remodeling

  2004cites this paper
• Differential Osteopontin Expression in Phenotypically Distinct Subclones of Murine Breast Cancer Cells Mediates Metastatic Behavior*

  2004cites this paper
• Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines

  2004cites this paper
• Transcriptional regulation of osteopontin and the metastatic phenotype: Evidence for a Ras-activated enhancer in the human OPN promoter

  2004cites this paper
• Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.

  2004cites this paper
• RESEARCH REVIEW The Role of Osteopontin in Tumor Metastasis

  2004cites this paper
• Osteopontin Stimulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells*

  2003cites this paper
• Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma

  2003cites this paper
• The role of osteopontin in lung disease.

  2003influential citation
• Minireview. Osteopontin: Roles in Implantation and Placentation1

  2003cites this paper
• Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.

  2002cites this paper
• Osteopontin--a molecule for all seasons.

  2002cites this paper
• Expression of Osteopontin (Eta-1) in Crohn Disease of the Terminal Ileum

  2002cites this paper
• Morphological and biological heterogeneity of three tumorigenic cell lines derived from a single p53-/- osteoblast-like cell line, MMC2.

  2002cites this paper
• Differential osteopontin expression in lung cancer.

  2001cites this paper
• The metastasis gene osteopontin: a candidate target for cancer therapy.

  2001cites this paper
• Role of osteopontin in cellular signaling and toxicant injury.

  2001cites this paper
• Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

  2000cites this paper
• Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

  2000cites this paper
• Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.

  2000cites this paper
• Transforming JB6 cells exhibit enhanced integrin‐mediated adhesion to osteopontin

  2000cites this paper
• Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation

  2000influential citation
• Substrate Specificity of αvβ3Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway Activation*

  2000cites this paper
• Articular Chondrocytes and Synovial Fibroblasts

  2000cites this paper
• Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

  1999cites this paper
• Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro.

  1999cites this paper
• Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice

  1999cites this paper
• STATEMENT A Approved for Public Release Distribution Unlimited FINAL

  1999cites this paper
• TPA-mediated regulation of osteopontin in human malignant glioma cells.

  1998cites this paper
• Osteopontin expression in a group of lymph node negative breast cancer patients

  1998cites this paper
• Detection of mouse osteopontin by western blotting.

  1998cites this paper
• Osteopontin expression in mammary gland development and tumorigenesis.

  1997cites this paper
• Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways

  1997cites this paper
• Interaction between CD44 and osteopontin as a potential basis for metastasis formation.

  1997cites this paper
• Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells.

  1997cites this paper
• Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology.

  1997cites this paper
• Immunodetection of Enamel‐ and Cementum‐Related (Bone) Proteins at the Enamel‐Free Area and Cervical Portion of the Tooth in Rat Molars

  1997cites this paper
• Ultrastructural localization of osteopontin immunoreactivity in phagolys osomes and secretory granules of cells in human intestine

  1997cites this paper
• Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women.

  1996cites this paper
• Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor*

  1996cites this paper